The Great Hold-Up: European Markets Tiptoe Ahead of Fed's Big Call
Midday Market Mayhem: Unpacking the Wild Swings of Qualcomm, Organon, and a Rising Star
The Biotech Gambit: Novartis Reportedly Eyes Avidity in a High-Stakes Acquisition
The Big Pharma Buzz: Why Novartis Might Be Eyeing Avidity's RNA Magic
Pharma's Unseen Shift: Citi's Meacham Reveals Deep-Rooted U.S. Investment Promises Already Underway